Healthcare & Life Sciences
Dice Therapeutics
United Stateswww.dicetherapeutics.com
Dice Therapeutics is a Healthcare & Life Sciences startup based in the United States, since acquired, 1 tracked investor.
Acquiredacquired
acquired
Stage
1
Investors
About Dice Therapeutics
Dice Therapeutics is a company headquartered in the United States. Dice Therapeutics has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Dice Therapeutics is a clinical-stage biotechnology company focused on developing innovative medicines in immunology and oncology. The company went public in 2021 under NASDAQ:DICE and was later acquired by Eli Lilly.
Explore Dice Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.